Loading...
Biologics as countermeasures for acute radiation syndrome: where are we now?
Despite significant scientific advances toward the development of a safe, nontoxic and effective radiation countermeasure for acute radiation syndrome (ARS) over the past six decades, no drug has been approved by the US FDA. Several biologics are currently under development as radiation countermeasu...
Saved in:
| Published in: | Expert Opin Biol Ther |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Informa Healthcare
2015
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4720033/ https://ncbi.nlm.nih.gov/pubmed/25416452 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/14712598.2015.986453 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|